Ultrasound Guided Erector Spinae Block Versus Thoracic Para-vertebral Block Versus Quadratus Lamborum Block in Open Renal Surgeries
1 other identifier
observational
48
1 country
1
Brief Summary
Open renal surgeries are associated with substantial postoperative pain, pain relief in patients undergoing this procedure is usually provided either by thoracic epidural analgesia (EA) or by systemic analgesics. EA is a very useful option for the management of postoperative pain in patients undergoing abdominal surgeries, but the risks and contraindications linked to EA like hypotension, headache, nerve damage or infection may limit its use. Systemic analgesics in the form of opioid analgesics may give rise to side effects like nausea ,vomiting , constipation , allergy or drowsiness and often provide insufficient analgesia. Hence, other methods of postoperative pain management are desired. Sensory level target according to the incision site Flank (T9-T11) , Thoraco-abdominal (T7-T12 ) and Trans-abdominal (T6-T10). Ultrasound (US) guided erector spinae plane (ESP) block is one of the interfascial plane blocks that target the dorsal and ventral rami of the spinal nerves. Although there is no sufficient evidence for the spread of local anesthetic to the ventral rami, recent reports demonstrated effective postoperative analgesia after thoracic and lumbar surgeries affecting both the ventral and dorsal rami. Paravertebral block (PVB) is a technique where a local anesthetic is deposited into a space found on both sides of the spine, called the paravertebral space. It is a block with a dermatomal distribution of pain relief depending on the level of the spine at which the block is sited and the quantity and type of deposited local anesthetic. PVB is effective for pain relief in the thoracic, abdominal and limb regions. primary aim was to compare postoperative opioid consumption rates at 24 h. Secondary end points were to compare pain scores and hemodynamic variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 14, 2023
CompletedFirst Posted
Study publicly available on registry
June 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedJune 8, 2023
June 1, 2023
11 months
May 14, 2023
June 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Total morphine requirements 24 hours postoperatively
24 hours post operative
Study Arms (4)
Erector spinea block
-ESPB Group (n=12): Received erector spinae plane block.
Thoracic Paravertebral block
TPVB Group (n=12) : Received thoracic paravertebral block.
Control group
Control Group (n=12): Received morphine (0.1 mg/kg iv) before skin incision .
QLB group
Quadratus lamborum block n=12
Interventions
Paravertebral block versus Erector spinea block versus quadratus lamborum block
Eligibility Criteria
This was randomized, controlled, single-blinded study, conducted in urology operating theatre, Al-Azhar university hospital. Forty eight patients of both sex and aged from 21-65 years in period between February 2022 to September 2023 scheduled for elective open renal surgeries under general anesthesia were enrolled in this study. The procedure was explained to the patient and informed consent was signed after his agreement then the patient was classified to one of three groups
You may not qualify if:
- Patient's refusal.
- Patients with ASA (III , IV) score.
- Coagulopathy to be cancelled if ( INR\>1.4 , Platelets count \<100x109 )
- Infection at the injection site.
- Allergy to local anesthetics.
- Patients receiving opioids for chronic analgesic therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azhar University
Cairo, 11765, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assisstant professor
Study Record Dates
First Submitted
May 14, 2023
First Posted
June 6, 2023
Study Start
February 1, 2023
Primary Completion
January 1, 2024
Study Completion
February 1, 2024
Last Updated
June 8, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share